Screener
Percentage of milestones (as a percent)
Ligand Pharmaceuticals·Products & Services·1 segment
Breakdown
Segments
Equity securities in Primrose BioView metric
| Segment | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|
| Equity securities in Primrose Bio | 50% | 50% | 50% | 50% |
| Total | 50% | 50% | 50% | 50% |